Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »


  • Oligomerix
  • 3960 Broadway, Suite 340D
  • New York NY, 10032

Oligomerix is a biopharmaceutical company focused on small molecule drug discovery, immunotherapy approaches, and biomarker assay development for Alzheimer’s disease (AD) and other neurodegenerative disorders. Its platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates.

Related To This Company